Table 1 Minimal inhibitory concentrations for 19OD2882, interpretation according to EUCAST clinical breakpoints where available

Ampicillin/sulbactam (2:1 ratio)

< 0.5/0.25

S

Cefotetan

< 4

-

Imipenem

< 0.12

S

Clindamycin

< 0.25

S

Metronidazole

8

R

Ampicillin

< 0.5

S

Tetracycline

< 0.25

-

Piperacillin/ tazobactam (constant 4)

< 0.25/4

S

Penicillin

< 0.06

S

Amoxicillin/ clavulanic acid 2:1 ratio

< 0.5/0.25

S

Cefoxitin

< 1

-

Chloramphenicol

< 2

S

Piperacillin

< 4

-

Mezlocillin

< 4

-

Meropenem

< 0.5

 S